UnknownNot Applicable

Residual Adrenal Function in Addison's Disease

Italy50 participantsStarted 2023-01-01

Plain-language summary

The main aim of this study is to assess the role of 11-deoxycortisol as surrogate marker of Residual adrenal function. 11-deoxycortisol levels will be assessed in all recruited patients

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Autoimmune Addison's disease * Informed consent Exclusion Criteria: \- Drugs affecting immune system or steroids other than hydrocortisone or cortisone acetate

What they're measuring

prevalence of RAF

Timeframe: baseline

Trial details

NCT IDNCT06309498

SponsorIstituto Auxologico Italiano

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-30

Contact for this trial

Valentina Morelli, PhD

02619112547 v.morelli@auxologico.it

View on ClinicalTrials.gov More Adrenal Insufficiency trials